ID   DGKE_HUMAN              Reviewed;         567 AA.
AC   P52429; Q8TBM4; Q9UKQ3;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   10-MAY-2017, entry version 154.
DE   RecName: Full=Diacylglycerol kinase epsilon;
DE            Short=DAG kinase epsilon;
DE            EC=2.7.1.107;
DE   AltName: Full=Diglyceride kinase epsilon;
DE            Short=DGK-epsilon;
GN   Name=DGKE; Synonyms=DAGK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=8626589; DOI=10.1074/jbc.271.17.10230;
RA   Tang W., Bunting M., Zimmerman G.A., McIntyre T.M., Prescott S.M.;
RT   "Molecular cloning of a novel human diacylglycerol kinase highly
RT   selective for arachidonate-containing substrates.";
RL   J. Biol. Chem. 271:10237-10241(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-154.
RX   PubMed=10571048; DOI=10.1016/S0378-1119(99)00345-5;
RA   Tang W., Bardien S., Bhattacharya S.S., Prescott S.M.;
RT   "Characterization of the human diacylglycerol kinase epsilon gene and
RT   its assessment as a candidate for inherited retinitis pigmentosa.";
RL   Gene 239:185-192(1999).
RN   [5]
RP   INVOLVEMENT IN NPHS7.
RX   PubMed=23274426; DOI=10.1681/ASN.2012090903;
RA   Ozaltin F., Li B., Rauhauser A., An S.W., Soylemezoglu O., Gonul I.I.,
RA   Taskiran E.Z., Ibsirlioglu T., Korkmaz E., Bilginer Y., Duzova A.,
RA   Ozen S., Topaloglu R., Besbas N., Ashraf S., Du Y., Liang C., Chen P.,
RA   Lu D., Vadnagara K., Arbuckle S., Lewis D., Wakeland B., Quigg R.J.,
RA   Ransom R.F., Wakeland E.K., Topham M.K., Bazan N.G., Mohan C.,
RA   Hildebrandt F., Bakkaloglu A., Huang C.L., Attanasio M.;
RT   "DGKE variants cause a glomerular microangiopathy that mimics
RT   membranoproliferative GN.";
RL   J. Am. Soc. Nephrol. 24:377-384(2013).
RN   [6]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND VARIANTS AHUS7 PRO-63
RP   AND PRO-273.
RX   PubMed=23542698; DOI=10.1038/ng.2590;
RA   Lemaire M., Fremeaux-Bacchi V., Schaefer F., Choi M., Tang W.H.,
RA   Le Quintrec M., Fakhouri F., Taque S., Nobili F., Martinez F., Ji W.,
RA   Overton J.D., Mane S.M., Nuernberg G., Altmueller J., Thiele H.,
RA   Morin D., Deschenes G., Baudouin V., Llanas B., Collard L.,
RA   Majid M.A., Simkova E., Nuernberg P., Rioux-Leclerc N., Moeckel G.W.,
RA   Gubler M.C., Hwa J., Loirat C., Lifton R.P.;
RT   "Recessive mutations in DGKE cause atypical hemolytic-uremic
RT   syndrome.";
RL   Nat. Genet. 45:531-536(2013).
RN   [7]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-99.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Highly selective for arachidonate-containing species of
CC       diacylglycerol (DAG). May terminate signals transmitted through
CC       arachidonoyl-DAG or may contribute to the synthesis of
CC       phospholipids with defined fatty acid composition.
CC   -!- CATALYTIC ACTIVITY: ATP + 1,2-diacyl-sn-glycerol = ADP + 1,2-
CC       diacyl-sn-glycerol 3-phosphate.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Multi-pass membrane
CC       protein {ECO:0000305}. Membrane {ECO:0000269|PubMed:23542698}.
CC       Cytoplasm {ECO:0000269|PubMed:23542698}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P52429-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P52429-2; Sequence=VSP_056957, VSP_056958;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed predominantly in testis. Expressed
CC       in endothelium, platelets and podocytes (at protein level).
CC       {ECO:0000269|PubMed:23542698}.
CC   -!- DISEASE: Nephrotic syndrome 7 (NPHS7) [MIM:615008]: A form of
CC       nephrotic syndrome, a renal disease clinically characterized by
CC       severe proteinuria, resulting in complications such as
CC       hypoalbuminemia, hyperlipidemia and edema. NPHS7 is an autosomal
CC       recessive form characterized by onset of proteinuria usually in
CC       the first decade of life. The disorder is progressive, and some
CC       patients develop end-stage renal disease within several years.
CC       Renal biopsy typically shows membranoproliferative
CC       glomerulonephritis. {ECO:0000269|PubMed:23274426}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Hemolytic uremic syndrome atypical 7 (AHUS7)
CC       [MIM:615008]: An atypical form of hemolytic uremic syndrome
CC       characterized by acute onset in the first year of life of
CC       microangiopathic hemolytic anemia, thrombocytopenia, and renal
CC       failure. After the acute episode, most patients develop chronic
CC       renal insufficiency. Unlike other genetic forms of aHUS, AHUS7 is
CC       not related to abnormal activation of the complement system.
CC       {ECO:0000269|PubMed:23542698}. Note=Disease susceptibility is
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the eukaryotic diacylglycerol kinase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U49379; AAC50497.1; -; mRNA.
DR   EMBL; AC015912; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106858; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC022297; AAH22297.1; -; mRNA.
DR   EMBL; AF136745; AAD45666.1; -; Genomic_DNA.
DR   CCDS; CCDS11590.1; -. [P52429-1]
DR   RefSeq; NP_003638.1; NM_003647.2. [P52429-1]
DR   UniGene; Hs.239514; -.
DR   ProteinModelPortal; P52429; -.
DR   BioGrid; 114096; 11.
DR   IntAct; P52429; 7.
DR   STRING; 9606.ENSP00000284061; -.
DR   ChEMBL; CHEMBL1075187; -.
DR   SwissLipids; SLP:000000546; -.
DR   iPTMnet; P52429; -.
DR   PhosphoSitePlus; P52429; -.
DR   SwissPalm; P52429; -.
DR   BioMuta; DGKE; -.
DR   DMDM; 1708625; -.
DR   EPD; P52429; -.
DR   MaxQB; P52429; -.
DR   PaxDb; P52429; -.
DR   PeptideAtlas; P52429; -.
DR   PRIDE; P52429; -.
DR   DNASU; 8526; -.
DR   Ensembl; ENST00000284061; ENSP00000284061; ENSG00000153933. [P52429-1]
DR   Ensembl; ENST00000572810; ENSP00000459295; ENSG00000153933. [P52429-2]
DR   GeneID; 8526; -.
DR   KEGG; hsa:8526; -.
DR   UCSC; uc002iur.4; human. [P52429-1]
DR   CTD; 8526; -.
DR   DisGeNET; 8526; -.
DR   GeneCards; DGKE; -.
DR   GeneReviews; DGKE; -.
DR   HGNC; HGNC:2852; DGKE.
DR   HPA; HPA017167; -.
DR   MalaCards; DGKE; -.
DR   MIM; 601440; gene.
DR   MIM; 615008; phenotype.
DR   neXtProt; NX_P52429; -.
DR   OpenTargets; ENSG00000153933; -.
DR   Orphanet; 357008; Atypical hemolytic-uremic syndrome with DGKE deficiency.
DR   Orphanet; 329903; Immunoglobulin-mediated membranoproliferative glomerulonephritis.
DR   PharmGKB; PA27313; -.
DR   eggNOG; KOG1169; Eukaryota.
DR   eggNOG; ENOG410XQVB; LUCA.
DR   GeneTree; ENSGT00760000119050; -.
DR   HOGENOM; HOG000220913; -.
DR   HOVERGEN; HBG051347; -.
DR   InParanoid; P52429; -.
DR   KO; K00901; -.
DR   OMA; GQDQFIP; -.
DR   OrthoDB; EOG091G096N; -.
DR   PhylomeDB; P52429; -.
DR   TreeFam; TF313104; -.
DR   BRENDA; 2.7.1.107; 2681.
DR   Reactome; R-HSA-114508; Effects of PIP2 hydrolysis.
DR   GenomeRNAi; 8526; -.
DR   PRO; PR:P52429; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000153933; -.
DR   CleanEx; HS_DGKE; -.
DR   ExpressionAtlas; P52429; baseline and differential.
DR   Genevisible; P52429; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; TAS:ProtInc.
DR   GO; GO:0004143; F:diacylglycerol kinase activity; IDA:BHF-UCL.
DR   GO; GO:0016301; F:kinase activity; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0046834; P:lipid phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0008654; P:phospholipid biosynthetic process; TAS:ProtInc.
DR   GO; GO:0030168; P:platelet activation; TAS:Reactome.
DR   GO; GO:0007205; P:protein kinase C-activating G-protein coupled receptor signaling pathway; IEA:InterPro.
DR   CDD; cd00029; C1; 2.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR000756; Diacylglycerol_kin_accessory.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00609; DAGK_acc; 1.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00045; DAGKa; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF111331; SSF111331; 1.
DR   PROSITE; PS50146; DAGK; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Hemolytic uremic syndrome; Kinase; Membrane;
KW   Metal-binding; Nucleotide-binding; Polymorphism; Reference proteome;
KW   Repeat; Transferase; Transmembrane; Transmembrane helix; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    567       Diacylglycerol kinase epsilon.
FT                                /FTId=PRO_0000218464.
FT   TRANSMEM     22     42       Helical. {ECO:0000255}.
FT   TRANSMEM    436    456       Helical. {ECO:0000255}.
FT   DOMAIN      215    356       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   ZN_FING      59    108       Phorbol-ester/DAG-type 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   ZN_FING     124    177       Phorbol-ester/DAG-type 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   VAR_SEQ     156    177       CIWCQKTVHDECMKNSLKNEKC -> YGLRGHSLSQNAPWE
FT                                SGFHRVV (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056957.
FT   VAR_SEQ     178    567       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056958.
FT   VARIANT      63     63       R -> P (in AHUS7; dbSNP:rs312262694).
FT                                {ECO:0000269|PubMed:23542698}.
FT                                /FTId=VAR_069804.
FT   VARIANT      99     99       L -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036120.
FT   VARIANT     273    273       R -> P (in AHUS7; dbSNP:rs312262695).
FT                                {ECO:0000269|PubMed:23542698}.
FT                                /FTId=VAR_069805.
SQ   SEQUENCE   567 AA;  63927 MW;  BC334AD15FB4D0B4 CRC64;
     MEAERRPAPG SPSEGLFADG HLILWTLCSV LLPVFITFWC SLQRSRRQLH RRDIFRKSKH
     GWRDTDLFSQ PTYCCVCAQH ILQGAFCDCC GLRVDEGCLR KADKRFQCKE IMLKNDTKVL
     DAMPHHWIRG NVPLCSYCMV CKQQCGCQPK LCDYRCIWCQ KTVHDECMKN SLKNEKCDFG
     EFKNLIIPPS YLTSINQMRK DKKTDYEVLA SKLGKQWTPL IILANSRSGT NMGEGLLGEF
     RILLNPVQVF DVTKTPPIKA LQLCTLLPYY SARVLVCGGD GTVGWVLDAV DDMKIKGQEK
     YIPQVAVLPL GTGNDLSNTL GWGTGYAGEI PVAQVLRNVM EADGIKLDRW KVQVTNKGYY
     NLRKPKEFTM NNYFSVGPDA LMALNFHAHR EKAPSLFSSR ILNKAVYLFY GTKDCLVQEC
     KDLNKKVELE LDGERVALPS LEGIIVLNIG YWGGGCRLWE GMGDETYPLA RHDDGLLEVV
     GVYGSFHCAQ IQVKLANPFR IGQAHTVRLI LKCSMMPMQV DGEPWAQGPC TVTITHKTHA
     MMLYFSGEQT DDDISSTSDQ EDIKATE
//
